These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 20167107)

  • 1. Whole brain radiotherapy with a conformational external beam radiation boost for lung cancer patients with 1-3 brain metastasis: a multi institutional study.
    Casanova N; Mazouni Z; Bieri S; Combescure C; Pica A; Weber DC
    Radiat Oncol; 2010 Feb; 5():13. PubMed ID: 20167107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome and prognostic factors in patients with brain metastases from small-cell lung cancer treated with whole brain radiotherapy.
    Bernhardt D; Adeberg S; Bozorgmehr F; Opfermann N; Hoerner-Rieber J; König L; Kappes J; Thomas M; Herth F; Heußel CP; Warth A; Debus J; Steins M; Rieken S
    J Neurooncol; 2017 Aug; 134(1):205-212. PubMed ID: 28560661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic treatment after whole-brain radiotherapy may improve survival in RPA class II/III breast cancer patients with brain metastasis.
    Zhang Q; Chen J; Yu X; Ma J; Cai G; Yang Z; Cao L; Chen X; Guo X; Chen J
    J Neurooncol; 2013 Sep; 114(2):181-9. PubMed ID: 23743596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A boost in addition to whole-brain radiotherapy improves patient outcome after resection of 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients.
    Rades D; Pluemer A; Veninga T; Dunst J; Schild SE
    Cancer; 2007 Oct; 110(7):1551-9. PubMed ID: 17654659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of X-ray stereotactic radiotherapy on brain metastases and prognostic analysis.
    Wei W; Deng ML; Wu SX; Zeng ZF; Li FY; Wang HY; Bao Y; Gao YH; Chen LX
    Chin J Cancer; 2010 Feb; 29(2):202-6. PubMed ID: 20109352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors affecting survival after whole brain radiotherapy in patients with brain metastasized lung cancer.
    Tsakonas G; Hellman F; Gubanski M; Friesland S; Tendler S; Lewensohn R; Ekman S; de Petris L
    Acta Oncol; 2018 Feb; 57(2):231-238. PubMed ID: 28984492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Institutional, retrospective analysis of 777 patients with brain metastases: treatment outcomes and diagnosis-specific prognostic factors.
    Antoni D; Clavier JB; Pop M; Schumacher C; Lefebvre F; Noël G
    Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):630-7. PubMed ID: 23582409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole brain radiotherapy for brain metastases from breast cancer: estimation of survival using two stratification systems.
    Viani GA; Castilho MS; Salvajoli JV; Pellizzon AC; Novaes PE; Guimarães FS; Conte MA; Fogaroli RC
    BMC Cancer; 2007 Mar; 7():53. PubMed ID: 17386108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of 2 whole-brain radiotherapy schedules and prognostic factors for brain metastases in breast cancer patients.
    Rades D; Lohynska R; Veninga T; Stalpers LJ; Schild SE
    Cancer; 2007 Dec; 110(11):2587-92. PubMed ID: 17893909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole-brain radiotherapy with 20 Gy in 5 fractions for brain metastases in patients with cancer of unknown primary (CUP).
    Rades D; Bohlen G; Lohynska R; Veninga T; Stalpers LJ; Schild SE; Dunst J
    Strahlenther Onkol; 2007 Nov; 183(11):631-6. PubMed ID: 17960339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypofractionated stereotactic radiotherapy with or without whole-brain radiotherapy for patients with newly diagnosed brain metastases from non-small cell lung cancer.
    Ma LH; Li G; Zhang HW; Wang ZY; Dang J; Zhang S; Yao L; Zhang XM
    J Neurosurg; 2012 Dec; 117 Suppl():49-56. PubMed ID: 23205789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Boost Irradiation Integrated to Whole Brain Radiotherapy in the Management of Brain Metastases.
    Dobi Á; Fodor E; Maráz A; Együd Z; Cserháti A; Tiszlavicz L; Reisz Z; Barzó P; Varga Z; Hideghéty K
    Pathol Oncol Res; 2020 Jan; 26(1):149-157. PubMed ID: 29344836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Additional radiation boost to whole brain radiation therapy may improve the survival of patients with brain metastases in small cell lung cancer.
    Sun H; Xu L; Wang Y; Zhao J; Xu K; Qi J; Yuan Z; Zhao L; Wang P
    Radiat Oncol; 2018 Dec; 13(1):250. PubMed ID: 30563554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole-brain radiotherapy plus sequential or simultaneous integrated boost for the treatment of a limited number of brain metastases in non-small cell lung cancer: A single-institution study.
    Qing D; Zhao B; Zhou YC; Zhu HL; Ma DY
    Cancer Med; 2020 Jan; 9(1):238-246. PubMed ID: 31749325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy.
    Caballero JA; Sneed PK; Lamborn KR; Ma L; Denduluri S; Nakamura JL; Barani IJ; McDermott MW
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):303-9. PubMed ID: 22079723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
    Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
    J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome and prognostic factors in single brain metastases from small-cell lung cancer.
    Bernhardt D; Adeberg S; Bozorgmehr F; Opfermann N; Hörner-Rieber J; König L; Kappes J; Thomas M; Unterberg A; Herth F; Heußel CP; Warth A; Debus J; Steins M; Rieken S
    Strahlenther Onkol; 2018 Feb; 194(2):98-106. PubMed ID: 29085978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of recursive partitioning analysis and evaluation of the use of whole brain radiation among patients treated with stereotactic radiosurgery for newly diagnosed brain metastases.
    Chidel MA; Suh JH; Reddy CA; Chao ST; Lundbeck MF; Barnett GH
    Int J Radiat Oncol Biol Phys; 2000 Jul; 47(4):993-9. PubMed ID: 10863070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereotactic radiosurgery alone versus resection plus whole-brain radiotherapy for 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients.
    Rades D; Bohlen G; Pluemer A; Veninga T; Hanssens P; Dunst J; Schild SE
    Cancer; 2007 Jun; 109(12):2515-21. PubMed ID: 17487853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of Survival of Patients with Brain Metastases According to Prognostic Indexes and Treatment Strategies.
    Saginc H; Baltalarli PB; Sagtas E; Coskun ME
    Turk Neurosurg; 2020; 30(6):822-831. PubMed ID: 32091122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.